Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |